SCHEMBL30815987

SCHEMBL30815987

CC(=O)OCCC(C[N+](C)(C)C)OP(=O)([O-])O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CHRM5 P08912 2/20 0.41
CHRM3 P20309 2/20 0.41
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
TBXA2R P21731 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PGR P06401 1/20 0.41
HTR1A P08908 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
CHRNA10 Q9GZZ6 1/20 0.41
CHRNA9 Q9UGM1 1/20 0.41
CYP1A2 P05177 1/20 0.41
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80350 0.86 THRB (0.36) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
SCHEMBL1260408 0.83 TSHR (0.37) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
Methacrylic Acid SCHEMBL5479590 0.83 LMNA (0.35) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
SCHEMBL6130068 0.80 MEN1 (0.33) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL17964294 0.80 TSHR (0.46) MEN1KMT2ALMNATSHRMAPT
SCHEMBL1692410 0.79 MEN1 (0.37) MEN1KMT2ACYP1A2HRH1LMNA
SCHEMBL14739090 0.79 MEN1 (0.35) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
SCHEMBL14989008 0.79 THRB (0.42) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
SCHEMBL31216396 0.78 TSHR (0.40) SMN1; SMN2MEN1KMT2ACYP1A2HRH1
SCHEMBL3630184 0.78 SLC25A20 (0.38) MEN1KMT2ACYP1A2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060936-A1 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS TECHNION RES & DEV FOUNDATION (IL) 2026-03-05 US claimed
WO-2024047639-A1 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2024-03-07 WO claimed
US-20260060936-A1 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS TECHNION RES & DEV FOUNDATION (IL) 2026-03-05 US disclosed
WO-2024047639-A1 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2024-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060936-A1 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS CHRM1, CHRNA6, OPRM1 CHRM1 1/4885SMN1; SMN2 565/4885CHRM5 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.